The global oncolytic virus therapy market size is expected to reach USD 866.1 Million at a steady CAGR of 23.9% in 2028, according to latest analysis by Emergen Research. Steady growth of oncolytic virus therapy market can be attributed to rising cancer incidence globally. Cancer is a major cause of deaths in countries across the globe and it is estimated that in 2020, over 1.8 million new cancer cases were diagnosed in the US, with over 0.6 Million deaths occurring due to the disease. Also, around 70% of cancer mortality occurs in low and middle-income countries.
Oncolytic virus therapy (a type of immunotherapy) uses engineered viruses to destroy cancer cells without affecting healthy cells in the human body. Once a cancer cell is destroyed, it releases cancer antigens that trigger immune responses to destroy other tumor cells in the body.
Get a sample copy of the Global Oncolytic Virus Therapy Market report @ https://www.emergenresearch.com/request-sample/541
Some Key Highlights in the Report
- In October 2020, Oncolytics Biotech made announced the signing of a partnership agreement with AIO and Roche to commence a Phase ½ trial(GOBLET) for gastrointestinal cancer. The trial would examine the use of pelareorep with anti-PD-L1 checkpoint inhibitor by Roche in cancer patients.
- Monoclonal antibodies are considered beneficial in stimulating immune responses to destroy cancer cells. In addition, certain monoclonal antibodies are capable of blocking the connection between the cellular growth promoting proteins and cancer cells, thereby killing the cancer cells.
- Key players in the market include Oncolytics Biotech Inc., Lokon Pharma AB, PsiOxus Therapeutics, Sorrento Therapeutics Inc., CG Oncology Inc., ORYX GmbH & Co. KG, VCNBiosciences, DNAtrix, Targovax, and SillaJen Inc.
Oncolytic Virus Therapy Market Segmentation:
Emergen Research has segmented the global oncolytic virus therapy market on the basis of type, application, end-use, and region:
- Type Outlook (Revenue, USD Million; 2024–2028)
- Monoclonal Antibodies
- Checkpoint Inhibitors
- Cancer Vaccines
- Immunomodulators
- Application Outlook (Revenue, USD Million; 2024–2028)
- Melanoma
- Lung Cancer
- Breast Cancer
- Others
- End-Use Outlook (Revenue, USD Million; 2024–2028)
- Hospitals
- Clinics
- Research Institutes
- Others
Key Geographical Segments:
- North America (U.S., Canada)
- Europe (U.K., Italy, Germany, France, Rest of EU)
- Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
- Latin America (Chile, Brazil, Argentina, Rest of Latin America)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Request a customized copy of the Oncolytic Virus Therapy market report @ https://www.emergenresearch.com/request-for-customization/541
Major Objectives of the Study:
- To offer a comprehensive analysis of the market scenario to derive an accurate forecast of the market and its major segments
- Accurate insights into the future growth prospects of the market through an analysis of the influencing factors
- Analysis of vital aspects of the market including cost analysis, supply chain analysis, Porter’s Five Forces analysis, SWOT analysis, and investment return analysis
- Extensive historical and forecast estimation of the market revenue based on its key segments and key regions
- Comprehensive analysis of the competitive landscape of the market along with exhaustive profiling of the key competitors, product portfolio, and manufacturing and production capabilities
- An accurate and comprehensive 8-year forecast for the Oncolytic Virus Therapy industry vertical on both regional and global scale
Table of Content:
Chapter 1. Methodology & Sources
1.1. Market Definition
1.2. Research Scope
1.3. Methodology
1.4. Research Sources
1.4.1. Primary
1.4.2. Secondary
1.4.3. Paid Sources
1.5. Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2020-2028
Chapter 3. Key Insights
Chapter 4. Oncolytic Virus Therapy Market Segmentation & Impact Analysis
4.1. Oncolytic Virus Therapy Market Material Segmentation Analysis
4.2. Industrial Outlook
4.2.1. Market indicators analysis
4.2.2. Market drivers’ analysis
4.2.2.1. Rising incidences of cancer
4.2.2.2. Increased investments in research and development
4.2.2.3. Growing awareness about early cancer detection
4.2.2.4. Growing geriatric population
4.2.3. Market restraints analysis
4.2.3.1. Cost prohibitive oncolytic virus therapy
4.3. Technological Insights
4.4. Regulatory Framework
4.5. Porter’s Five Forces Analysis
4.6. Competitive Metric Space Analysis
4.7. Price trend Analysis
4.8. Covid-19 Impact Analysis
READ MORE…!
To read more about this report, visit @ https://www.emergenresearch.com/industry-report/oncolytic-virus-therapy-market
Thank you for reading our report. Kindly get in touch with us to know more about the report or about customization options. Our team will ensure the report is tailored according to your needs.
Read similar reports by Emergen Research:
Virtual Diagnostics Market@ https://www.google.ge/url?q=https://www.emergenresearch.com/industry-report/virtual-diagnostics-market
3D Printing Healthcare Market@ https://www.google.com.gh/url?q=https://www.emergenresearch.com/industry-report/3d-printing-healthcare-market
Spherical Graphite Market@ https://www.google.com.gi/url?q=https://www.emergenresearch.com/industry-report/spherical-graphite-market
Digital Biomarkers Market@ https://www.google.gr/url?q=https://www.emergenresearch.com/industry-report/digital-biomarkers-market
Sodium Dichromate Market@ https://www.google.gl/url?q=https://www.emergenresearch.com/industry-report/sodium-dichromate-market
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: [email protected]
